Latest News

Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

Many glioblastoma patients treated with bevacizumab (AvastinŽ) have significant deterioration in neurocognitive function, symptoms and quality of life.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Most published medical research is false; Here's how to improve

  • How troubled marriage, depression history promote obesity

  • Bogus recycling bins help identify drinking patterns among low-income seniors

  • Understanding drinking behaviors among women with unwanted pregnancies

  • Bar attendance supports heavy drinking by young adults in the US-Mexico border region

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Memory decline among menopausal women could be next research frontier for hypnotic relaxation therapy

  • Immersed in violence: How 3-D gaming affects video game players

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  •